Holen Sie sich die Stockscreener-App
5.91
0.34%
0.02
Handel nachbörslich:
5.81
-0.10
-1.69%
Schlusskurs vom Vortag:
$5.89
Offen:
$5.91
24-Stunden-Volumen:
4,015
Relative Volume:
0.17
Marktkapitalisierung:
$24.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.56M
KGV:
-0.3514
EPS:
-16.82
Netto-Cashflow:
$-12.46M
1W Leistung:
-3.27%
1M Leistung:
+1.90%
6M Leistung:
-19.04%
1J Leistung:
+46.65%
1-Tages-Spanne:
$5.85
$5.935
1-Wochen-Bereich:
$5.78
$6.11
52-Wochen-Spanne:
$3.25
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Firmenname
Tenax Therapeutics Inc
Sektor
Branche
Telefon
919-855-2100
Adresse
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Vergleichen Sie TENX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
5.91 | 24.43M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-24 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-14 | Eingeleitet | Guggenheim | Buy |
| 2024-09-30 | Eingeleitet | William Blair | Outperform |
| 2017-05-18 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Eingeleitet | MLV & Co | Buy |
| 2014-11-18 | Eingeleitet | WallachBeth | Buy |
Alle ansehen
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
Tenax Therapeutics: Q2 Earnings Snapshot - NewsTimes
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Bluefield Daily Telegraph
Tenax's Heart Failure Drug Trial Grows Larger: Company Reveals Strong $105M Cash Position Through 2027 - Stock Titan
Is Tenax Therapeutics Inc. forming a reversal patternMarket Growth Summary & AI Driven Stock Movement Reports - Newser
How to manage a losing position in Tenax Therapeutics Inc.2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Using RSI to spot recovery in Tenax Therapeutics Inc.July 2025 Sector Moves & Risk Controlled Stock Alerts - Newser
Can a trend reversal in Tenax Therapeutics Inc. lead to recoveryJuly 2025 PreEarnings & Capital Efficient Trading Techniques - Newser
Tools to assess Tenax Therapeutics Inc.’s risk profile2025 Volatility Report & Stock Portfolio Risk Control - Newser
Is Tenax Therapeutics Inc. reversing from oversold territoryTreasury Yields & Fast Moving Stock Trade Plans - Newser
Will Tenax Therapeutics Inc. benefit from macro trendsPortfolio Return Summary & Long-Term Capital Growth Ideas - Newser
Multi factor analysis applied to Tenax Therapeutics Inc.July 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - Newser
Does Tenax Therapeutics Inc. fit your quant trading modelPortfolio Risk Summary & Accurate Trade Setup Notifications - Newser
Developing predictive dashboards with Tenax Therapeutics Inc. dataFree Daily Profit Focused Stock Screener - Newser
Using data filters to optimize entry into Tenax Therapeutics Inc.Predictable Entry Strategy With Technical Backing - Newser
Published on: 2025-08-11 21:10:29 - Newser
Tenax Therapeutics Inc. stock trendline breakdownMinimal Risk Growth Investment Opportunity Analysis - Newser
Tenax Therapeutics Inc. Volume Confirms Breakout — Analysts BullishOversold Recovery Opportunity Stocks Attract Buyers - beatles.ru
Statistical indicators supporting Tenax Therapeutics Inc.’s strength [2025 Biggest Moves]Smart Swing Trading Techniques - Newser
Tenax Therapeutics (TENX) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Risk adjusted return profile for Tenax Therapeutics Inc. analyzedFree Buy Signal Based on Chart Analysis - Newser
Will Tenax Therapeutics Inc. bounce back from current supportFree Real-Time Market Sentiment Tracking Tool - Newser
How Tenax Therapeutics Inc. stock performs during market volatilityTrading Opportunities Forecast by AI Insight - Newser
Tenax Therapeutics Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Short Interest Drops in Tenax Therapeutics Inc. After RallyEarnings Play Trade Plan With Alerts Shared - metal.it
What are the latest earnings results for Tenax Therapeutics Inc.Build wealth with long-term growth strategies - Jammu Links News
What is the risk reward ratio of investing in Tenax Therapeutics Inc. stockGet timely alerts on top-performing stocks - Jammu Links News
How strong is Tenax Therapeutics Inc. company’s balance sheetUnlock exclusive trading strategies - Jammu Links News
Is Tenax Therapeutics Inc. a growth stock or a value stockCapitalize on market trends with expert guidance - Jammu Links News
What analysts say about Tenax Therapeutics Inc. stockUnlock powerful trading signals and alerts - Jammu Links News
What are Tenax Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
What is BHFAM company’s growth strategyExceptional market positioning - Jammu Links News
Why is Tenax Therapeutics Inc. stock attracting strong analyst attentionExceptional profit velocity - Jammu Links News
What catalysts could drive Tenax Therapeutics Inc. stock higher in 2025Maximize portfolio returns with smart trading - Jammu Links News
What are analysts’ price targets for Tenax Therapeutics Inc. in the next 12 monthsRemarkably fast returns - Jammu Links News
Is it the right time to buy Tenax Therapeutics Inc. stockMaximize returns with strategic stock selection - jammulinksnews.com
What makes Tenax Therapeutics Inc. stock price move sharplyShort Term Gain Analysis Plan - beatles.ru
Relative strength of Tenax Therapeutics Inc. in sector analysisConsistent Gain Plan with AI Support - Newser
Visual analytics tools that track Tenax Therapeutics Inc. performancePrice Action Based Buy Zone Forecast - Newser
Why Tenax Therapeutics Inc. stock is on top investor watchlistsTen-Year Sector Performance and Summary Analysis - Newser
Long term hold vs stop loss in Tenax Therapeutics Inc.Real-Time Investment Picks with Accuracy - Newser
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):